Healthcare and Life Science
First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the first patient has been dosed in the US under its Investigational New Drug (IND) Application in Avacta’s phase 1 multi-centre trial evaluating...
New study - Breath test can monitor metabolism at home
First applied research to evaluate device finds it may detect changes linked to diet. ...
US patent granted protecting proprietary formulations of monoclonal antibodies
Endorses potential of proprietary Arestat™ platform technology to invent novel, enhanced therapeutics in $210 billion monoclonal antibody market Further strengthens Group’s extensive patent portfolio Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’...
Will the PSTN switch-off affect your business or school?
In December 2025, phone lines in the UK will go fully digital, and the remaining analogue phone lines – the Public Switch Telephone Network (PSTN) – will be permanently switched off. ...
Cresset appoints first Chief Financial Officer
As a consequence of recent investment from Scottish Equity Partners, we are delighted to welcome John Leighton to the Board and Executive Management team. ...
Guardtech Group raising the bar with new Cleanroom Solutions website
Haverhill cleanroom construction company elevate their turnkey offering with launch of ground-breaking new website ...
Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer
3DSecret funded by European Innovation Council’s Pathfinder Open 2022, established under the EU Horizon Europe program Consortium to leverage novel microfluidic technology to culture 3D cancer models for multi-parametric analysis, to inform cancer diagnostic and therapeutic developm...
CMR Surgical wins an inaugural King’s Award for Innovation
CMR has been awarded a King’s Award for Enterprise for Innovation for Versius, its small and modular next-generation surgical robotic system. The newly renamed King’s Award for Enterprise celebrates outstanding achievement by UK businesses ...
Maxion Therapeutics awarded £2 million Innovate UK funding to develop ion channel antibodies for “hard-to-treat" autoimmune diseases
Biotechnology company Maxion Therapeutics announces it has been awarded a prestigious GBP £2 million grant from Innovate UK, as part of its Biomedical Catalyst 2022 Round 2: Industry-led R&D funding competition. ...
New Director for unique science for health think-tank PHG Foundation
The PHG Foundation is delighted to confirm Dr Peter Mills as its next Director. The announcement was made as the PHG Foundation celebrated its 25th Anniversary at a gala dinner on Thursday 20 April at Trinity College, Cambridge. Pete is currently an Associate Director at the UK’s Nuffi...